Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Completed Phase 1 Trials for Selumetinib (DB11689)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02503358Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerTreatment